Arbutus Biopharma Corporation – Filings and Transcripts

NASDAQ: ABUS
Share price (11/6/26): $3.65
Market cap (11/6/26): $560 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Issuer tender offer – amended

Issuer tender offer – amended

Issuer tender offer

Info about tender offer or issuer

Registration of securities for employees

Ownership Filter

Beardsley Robert A

Androski Lindsay

News Filter

Announces FDA Clinical Hold Is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor

Announces Intent to Repurchase Up to US$230 Million of Its Common Shares Through Modified “Dutch Auction” Tender Offer

Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC